Strontium ranelate (Bivalos): its place in therapy for post-menopasal osteoporosis (analysis of clinical trials)
https://doi.org/10.14341/probl200753549-53
Abstract
Postmenopausal osteoporosis is a progressive systemic disease of the skeleton, characterized by a decrease in bone mass and a violation of the architectonics of bones, accompanied by an increased tendency to fractures. Osteoporosis is an important medical and social problem due to its high prevalence and frequent complications - skeleton bone fractures, which lead to temporary and permanent disability, worsen the quality of life, and increase mortality, especially among the elderly. According to various authors, mortality rates during the 1st year after a femoral neck fracture range from 12 to 40%. In half of the patients who survived after the fracture, the ability to self-care is significantly limited or lost.
About the Authors
E. G. ZotkinSt. Petersburg City Hospital No. 25
Russian Federation
City Rheumatology Center; City center for the prevention of osteoporosis
I. Eger
Clinic of Rheumatology; Institute of Physiotherapeutic Medicine
Switzerland
Osteoporosis Center with Clinical Research Department
S. Blumhardt
Clinic of Rheumatology; Institute of Physiotherapeutic Medicine
Switzerland
Osteoporosis Center with Clinical Research Department
В Jubelhart
Geneva University Hospital
Switzerland
Department of Geriatrics, Rehabilitation and Bone System Diseases
D. Jubelhart
Clinic of Rheumatology; Institute of Physiotherapeutic Medicine
Switzerland
Department of Geriatrics, Rehabilitation and Bone System Diseases
References
1. Аттапп Р. // Osteoporos. Int. - 2002. - Vol. 13. - Suppl. - P. S24.
2. Аттапп P., Shen V., Robin B. et al. // J. Bone Miner. Res. - 2004. - Vol. 19, N 12. - P. 2012-2020.
3. Bain S. et al. // J. Bone Miner. Res. - 2003. - Vol. 18. - Suppl. - P. S463.
4. Baron R., Tsouderos Y. // Eur. J. Pharmacol. - 2002. - Vol. 450, N 1. - P. 11-17.
5. Boivin G., Deloffre P., Perrat В. et al. // J. Bone Miner. Res. - 1996. - Vol. 11. - Suppl. - P. S1302-S1311.
6. Canalis E, Hott M., Deloffre P. et al. // Bone. - 1996. - Vol. 18, N6.-P. 517-523.
7. Marie P. J., Hott M., Modrowski D. et al. // J. Bone Miner. Res. - 1993. - Vol. 8, N 5. - P. 607-615.
8. Meunier P. J., Slosman D., Delmas P. D. et al. // J. Clin. Endocrinol. Metab. - 2002. - Vol. 87, N 5. - P. 2060-2066.
9. Meunier P. J., Roux C, Seeman E. et al. // N. Engl. J. Med. -2004. - Vol. 350, N 5. - P. 459-468.
10. Reginster J. У., Derolsy A, Dougados M. et al. // Osteoporos. Int. - 2002. - Vol. 13, N 12. - P. 925-931.
11. Reginster J. Y., Seeman E., De Vemejoul M. С et al. // J. Clin. Endocrinol. Metab. - 2005. - Vol. 90, N 5. - P. 2816-2822.
12. Takahashi N., Sasaki Т., Tsouderos Y. et al. // J. Bone Miner. Res. - 2003. - Vol. 18, N 6. - P. 1082-1087.
Review
For citations:
Zotkin E.G., Eger I., Blumhardt S., Jubelhart В., Jubelhart D. Strontium ranelate (Bivalos): its place in therapy for post-menopasal osteoporosis (analysis of clinical trials). Problems of Endocrinology. 2007;53(5):49-53. (In Russ.) https://doi.org/10.14341/probl200753549-53
Views:
1915
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
.jpg){kind=logo}
